
<ns0:uwmetadata xmlns:ns0="http://phaidra.univie.ac.at/XML/metadata/V1.0" xmlns:ns1="http://phaidra.univie.ac.at/XML/metadata/lom/V1.0" xmlns:ns10="http://phaidra.univie.ac.at/XML/metadata/provenience/V1.0" xmlns:ns11="http://phaidra.univie.ac.at/XML/metadata/provenience/V1.0/entity" xmlns:ns12="http://phaidra.univie.ac.at/XML/metadata/digitalbook/V1.0" xmlns:ns13="http://phaidra.univie.ac.at/XML/metadata/etheses/V1.0" xmlns:ns2="http://phaidra.univie.ac.at/XML/metadata/extended/V1.0" xmlns:ns3="http://phaidra.univie.ac.at/XML/metadata/lom/V1.0/entity" xmlns:ns4="http://phaidra.univie.ac.at/XML/metadata/lom/V1.0/requirement" xmlns:ns5="http://phaidra.univie.ac.at/XML/metadata/lom/V1.0/educational" xmlns:ns6="http://phaidra.univie.ac.at/XML/metadata/lom/V1.0/annotation" xmlns:ns7="http://phaidra.univie.ac.at/XML/metadata/lom/V1.0/classification" xmlns:ns8="http://phaidra.univie.ac.at/XML/metadata/lom/V1.0/organization" xmlns:ns9="http://phaidra.univie.ac.at/XML/metadata/histkult/V1.0">
  <ns1:general>
    <ns1:identifier>o:3075</ns1:identifier>
    <ns1:title language="en">Non-Contrast-Enhanced Multiparametric MRI of the Hypoxic Tumor Microenvironment Allows Molecular Subtyping of Breast Cancer: A Pilot Study</ns1:title>
    <ns1:language>en</ns1:language>
    <ns1:description language="en">Tumor neoangiogenesis is an important hallmark of cancer progression, triggered by alternating selective pressures from the hypoxic tumor microenvironment. Non-invasive, non-contrast-enhanced multiparametric MRI combining blood-oxygen-level-dependent (BOLD) MRI, which depicts blood oxygen saturation, and intravoxel-incoherent-motion (IVIM) MRI, which captures intravascular and extravascular diffusion, can provide insights into tumor oxygenation and neovascularization simultaneously. Our objective was to identify imaging markers that can predict hypoxia-induced angiogenesis and to validate our findings using multiplexed immunohistochemical analyses. We present an in vivo study involving 36 female athymic nude mice inoculated with luminal A, Her2+, and triple-negative breast cancer cells. We used a high-field 9.4-tesla MRI system for imaging and subsequently analyzed the tumors using multiplex immunohistochemistry for CD-31, PDGFR-Î², and Hif1-Î±. We found that the hyperoxic-BOLD-MRI-derived parameter ÎR2* discriminated luminal A from Her2+ and triple-negative breast cancers, while the IVIM-derived parameter fIVIM discriminated luminal A and Her2+ from triple-negative breast cancers. A comprehensive analysis using principal-component analysis of both multiparametric MRI- and mpIHC-derived data highlighted the differences between triple-negative and luminal A breast cancers. We conclude that multiparametric MRI combining hyperoxic BOLD MRI and IVIM MRI, without the need for contrast agents, offers promising non-invasive markers for evaluating hypoxia-induced angiogenesis.</ns1:description>
    <ns1:keyword language="en">Angiogenesis; Hallmarks; Diffusion; Expression; Pericytes; Receptor; Benign; Hif-1</ns1:keyword>
    <ns2:identifiers>
      <ns2:resource>1552099</ns2:resource>
      <ns2:identifier>10.3390/cancers16020375</ns2:identifier>
    </ns2:identifiers>
  </ns1:general>
  <ns1:lifecycle>
    <ns1:upload_date>2024-06-06T09:33:55.711Z</ns1:upload_date>
    <ns1:status>44</ns1:status>
    <ns2:peer_reviewed>yes</ns2:peer_reviewed>
    <ns1:contribute seq="0">
      <ns1:role>46</ns1:role>
      <ns1:entity seq="0">
        <ns3:firstname>Silvester J.</ns3:firstname>
        <ns3:lastname>Bartsch</ns3:lastname>
        <ns3:institution>Medical University of Vienna</ns3:institution>
      </ns1:entity>
      <ns1:entity seq="7">
        <ns3:firstname>KlÃ¡ra</ns3:firstname>
        <ns3:lastname>BroÅ¾ovÃ¡</ns3:lastname>
        <ns3:institution>University of Veterinary Medicine Vienna / Medical University of Vienna</ns3:institution>
        <ns3:type>person</ns3:type>
        <ns3:orcid>0000-0002-0050-9478</ns3:orcid>
      </ns1:entity>
      <ns1:entity seq="8">
        <ns3:firstname>Viktoria</ns3:firstname>   
     <ns3:lastname>Ehret</ns3:lastname>
        <ns3:institution>Medical University of Vienna</ns3:institution>
        <ns3:type>person</ns3:type>
        <ns3:orcid>0000-0003-1487-8693</ns3:orcid>
      </ns1:entity>
      <ns1:entity seq="6">
        <ns3:firstname>Joachim</ns3:firstname>
        <ns3:lastname>Friske</ns3:lastname>
        <ns3:institution>Medical University of Vienna</ns3:institution>
        <ns3:type>person</ns3:type>
      </ns1:entity>
      <ns1:entity seq="5">
        <ns3:firstname>Christoph</ns3:firstname>
        <ns3:lastname>FÃ¼rbÃ¶ck</ns3:lastname>
        <ns3:institution>Medical University of Vienna</ns3:institution>
        <ns3:type>person</ns3:type>
      </ns1:entity>
      <ns1:entity seq="4">
        <ns3:firstname>Lukas</ns3:firstname>
        <ns3:lastname>Kenner</ns3:lastname>
        <ns3:institution>University of Veterinary Medicine Vienna / Medical University of Vienna</ns3:institution>
        <ns3:type>person</ns3:type>
        <ns3:orcid>0000-0003-2184-1338</ns3:orcid>
      </ns1:entity>
      <ns1:entity seq="3">
        <ns3:firstname>Daniela</ns3:firstname>
        <ns3:lastname>Laimer-Gruber</ns3:lastname>
        <ns3:institution>Medical University of Vienna</ns3:institution>
        <ns3:type>person</ns3:type>
      </ns1:entity>
      <ns1:entity seq="2">
        <ns3:firstname>Thomas H.</ns3:firstname>
        <ns3:lastname>Helbich</ns3:lastname>
        <ns3:institution>Medical University of Vienna</ns3:institution>
        <ns3:type>person</ns3:type>
        <ns3:orcid>0000-0003-3169-778X</ns3:orcid>
      </ns1:entity>
      <ns1:entity seq="1">
        <ns3:firstname>Katja</ns3:firstname>
        <ns3:lastname>Pinker</ns3:lastname>
        <ns3:institution>Memorial Sloan Kettering Cancer Center</ns3:institution>
        <ns3:type>person</ns3:type>
        <ns3:orcid>0000-0002-2722-7331</ns3:orcid>
      </ns1:entity>
    </ns1:contribute>
  </ns1:lifecycle>
  <ns1:technical>
    <ns1:format>application/pdf</ns1:format>
    <ns1:size>709340</ns1:size>
    <ns1:location>https://phaidra.vetmeduni.ac.at/o:3075</ns1:location>
  </ns1:technical>
  <ns1:rights>
    <ns1:cost>no</ns1:cost>
    <ns1:copyright>yes</ns1:copyright>
    <ns1:license>16</ns1:license>
  </ns1:rights>
  <ns1:classification>
    <ns1:purpose>70</ns1:purpose>
  </ns1:classification>
  <ns1:organization>
    <ns8:hoschtyp>1552253</ns8:hoschtyp>
  </ns1:organization>
  <ns12:digitalbook>
    <ns12:name_magazine language="en">Cancers</ns12:name_magazine>
    <ns12:pagination>14</ns12:pagination>
    <ns12:volume>16</ns12:volume>
    <ns12:booklet>2</ns12:booklet>
    <ns12:publisher>MDPI</ns12:publisher>
    <ns12:releaseyear>2024</ns12:releaseyear>
  </ns12:digitalbook>
</ns0:uwmetadata>
